Skip to content

Angus Dalgleish

Angus Dalgleish: “


Angus George Dalgleish Bsc (Hons), MD FRACPath FRACP FRCP FMedSci has contributed to the fields of cancer immunology and HIV research.

Dalgleish identified CD4 as the receptor for HIV, a discovery that elucidated the mechanism of HIV infection and led to the development of effective anti-HIV strategies.

He is Foundation Professor of Oncology at St. George’s University of London[]. He is a consultant and Research Director of Onyvax Ltd [], a biotech company developing an allogeneic whole prostate [[cancer vaccine]].

(Via Wikipedia – New pages [en].)

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar